XML 48 R38.htm IDEA: XBRL DOCUMENT v3.21.2
Debt (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Feb. 21, 2020
Sep. 30, 2021
Sep. 30, 2021
Sep. 30, 2020
Debt Instrument [Line Items]        
Total long-term debt   $ 615,867 $ 615,867  
Interest shortfall on 2035 notes, net     5,713 $ 10,144
Principal payment on notes     10,730 $ 235,347
Issuer II Class C Units        
Debt Instrument [Line Items]        
Percentage of equity interest 75.00%      
9.5% Non-Recourse 2035 Notes        
Debt Instrument [Line Items]        
Principal amount $ 400,000 413,291 413,291  
Less: 5% retained by the Company   (20,665) (20,665)  
Unamortized debt issuance costs   (3,203) (3,203)  
Total long-term debt   $ 388,100 $ 388,100  
Interest rate (as a percent) 9.50% 9.50% 9.50%  
Percentage of note to be sold 95.00%      
Percentage of note to be retained 5.00%      
Net principal   $ 392,600 $ 392,600  
Estimated fair value   384,800 384,800  
9.0% Non-Recourse 2033 Notes        
Debt Instrument [Line Items]        
Unamortized debt issuance costs   $ (1,323) $ (1,323)  
Interest rate (as a percent)   9.00% 9.00%  
3.25% Convertible Senior Notes Due 2023        
Debt Instrument [Line Items]        
Principal amount   $ 230,000 $ 230,000  
Unamortized debt issuance costs   (2,233) (2,233)  
Total long-term debt   $ 227,767 $ 227,767  
Interest rate (as a percent)   3.25% 3.25% 3.25%
Notes fair value   $ 212,800 $ 212,800  
TRC        
Debt Instrument [Line Items]        
Percentage of economic interest 85.00%   85.00%  
Net interest shortfall   $ 5,700    
Percentage of equity interest   85.00% 85.00%  
Principal payment on notes     $ 5,000  
TRC | Minimum        
Debt Instrument [Line Items]        
Upward tiering royalties (as a percent) 6.50%      
TRC | Maximum        
Debt Instrument [Line Items]        
Upward tiering royalties (as a percent) 10.00%      
TRC | Issuer II Class C Units        
Debt Instrument [Line Items]        
Percentage of economic interest 63.75%      
Theravance Biopharma R&D, Inc. | 9.5% Non-Recourse 2035 Notes        
Debt Instrument [Line Items]        
Interest rate (as a percent)   5.00% 5.00%